Study on the application of alprostadil and benazepril in patients with diabetes and the effect on blood glucose fluctuation
10.3969/j.issn.1005-1678.2017.06.062
- VernacularTitle:前列地尔联合贝那普利在糖尿病患者中的应用及对血糖波动的影响研究
- Author:
Yuyuan WU
;
Ximei KE
;
Yu HE
- Keywords:
diabetes;
alprostadil;
benazepril;
blood glucose
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(6):167-169
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the effects of alprostadil combined with benazepril in the treatment of diabetes and the effect on blood glucose fluctuation.MethodsEighty cases with diabetes were randomly divided into the control group and the observation group with 40 cases in each group.The control group was treated with benazepril while the observation group was additionally treated with alprostadil.The treatment effects, the changes of blood glucose, blood lipids and renal function were compared between the two groups, and the incidence of adverse reactions was recorded.ResultsThe total effective rate in the observation group was higher than that in the control group (P<0.05).After treatment, the fasting plasma glucose (FPG), postprandial 2h plasma glucose (2hPG) and glycosylated hemoglobin (HbA1c) were reduced to the normal level but the volatility differences of FPG and 2hPG in the observation group were lower than those in the control group (P<0.05).After 4 weeks of treatment, the total cholesterol (TC), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C) decreased while high-density lipoprotein cholesterol (HDL-C) increased (P<0.05) but the differences between the two groups showed no statistical significance.After treatment, the improvement of renal function indexes in the observation group was better than that in the control group (P<0.05), and the incidence of adverse reactions showed no significant difference between the two groups.ConclusionThe application of alprostadil combined with benazepril in the treatment of diabetes can reduce blood glucose fluctuation, improve renal function, and reduce the risk of diabetic nephropathy.
